Reach Pharma Target Groups Successfully With Welect – Compliant With Data Protection Regulations Despite META, GDPR & DSA
The Major Challenges for Pharma and Healthcare Companies in Online Advertising from 2025 Onward
- Since January 2025, META has significantly restricted advertising in the healthcare sector.
- The Digital Services Act (DSA) strictly prohibits the use of profiling based on sensitive data, as outlined in Article 26, Paragraph 3.
- Advertising for pharmaceutical products requires targeting niche audiences that are difficult to define and reach.
- People often don’t know when a product becomes relevant to them—meaning that marketing departments cannot anticipate and target these moments effectively.
Our Solution: Choice-Driven Advertising (CDA)
With Choice-Driven Advertising, people themselves decide whether a promoted product is relevant to them based on their circumstances—without the need for personal data, tracking, or retargeting.
Welect provides a solution that delivers pharma advertising to the right people without violating the regulations set by META, GDPR, or DSA.
With Choice-Driven Ads, you can reach target audiences that are either invisible or too specific for traditional targeting. A few examples include:
- People experiencing hair loss (regardless of gender or age, with causes ranging from genetics and hormones to stress, illness, or environmental factors).
- People who suffer from allergy symptoms in summer, autumn, or winter.
- People with acute conditions such as headaches or cold symptoms, independent of gender or age.
Bayer Vital is already successfully using Choice-Driven Advertising and, together with Welect, has won the German Online Communication Award 2024 in the 'Chemistry & Pharma' category. More details on the case can be found here